nodes	percent_of_prediction	percent_of_DWPC	metapath
Selegiline—CYP2A6—Progesterone—uterine cancer	0.102	0.149	CbGbCtD
Selegiline—CYP2C8—Medroxyprogesterone Acetate—uterine cancer	0.0758	0.111	CbGbCtD
Selegiline—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0529	0.0776	CbGbCtD
Selegiline—CYP2C8—Progesterone—uterine cancer	0.0502	0.0737	CbGbCtD
Selegiline—CYP2C19—Progesterone—uterine cancer	0.0421	0.0618	CbGbCtD
Selegiline—CYP1A2—Progesterone—uterine cancer	0.0389	0.057	CbGbCtD
Selegiline—CYP2C9—Progesterone—uterine cancer	0.035	0.0514	CbGbCtD
Selegiline—ABCB1—Progesterone—uterine cancer	0.034	0.0499	CbGbCtD
Selegiline—CYP2D6—Progesterone—uterine cancer	0.032	0.047	CbGbCtD
Selegiline—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0307	0.0451	CbGbCtD
Selegiline—CYP2E1—Etoposide—uterine cancer	0.0301	0.0441	CbGbCtD
Selegiline—ABCB1—Dactinomycin—uterine cancer	0.027	0.0395	CbGbCtD
Selegiline—CYP2C8—Etoposide—uterine cancer	0.0225	0.033	CbGbCtD
Selegiline—CYP3A4—Progesterone—uterine cancer	0.0204	0.0299	CbGbCtD
Selegiline—CYP2B6—Doxorubicin—uterine cancer	0.0202	0.0297	CbGbCtD
Selegiline—CYP1A2—Etoposide—uterine cancer	0.0174	0.0255	CbGbCtD
Selegiline—ABCB1—Etoposide—uterine cancer	0.0152	0.0223	CbGbCtD
Selegiline—ABCB1—Doxorubicin—uterine cancer	0.0104	0.0152	CbGbCtD
Selegiline—CYP2D6—Doxorubicin—uterine cancer	0.00978	0.0143	CbGbCtD
Selegiline—CYP3A4—Etoposide—uterine cancer	0.00912	0.0134	CbGbCtD
Selegiline—CYP3A4—Doxorubicin—uterine cancer	0.00622	0.00912	CbGbCtD
Selegiline—MAOB—myometrium—uterine cancer	0.000965	0.0415	CbGeAlD
Selegiline—MAOA—myometrium—uterine cancer	0.000824	0.0354	CbGeAlD
Selegiline—MAOB—uterine cervix—uterine cancer	0.000751	0.0323	CbGeAlD
Selegiline—MAOB—decidua—uterine cancer	0.000716	0.0307	CbGeAlD
Selegiline—MAOB—renal system—uterine cancer	0.000703	0.0302	CbGeAlD
Selegiline—CYP2A6—vagina—uterine cancer	0.00069	0.0296	CbGeAlD
Selegiline—MAOB—endometrium—uterine cancer	0.00068	0.0292	CbGeAlD
Selegiline—MAOB—mammalian vulva—uterine cancer	0.000657	0.0282	CbGeAlD
Selegiline—MAOA—uterine cervix—uterine cancer	0.000641	0.0275	CbGeAlD
Selegiline—MAOB—uterus—uterine cancer	0.000626	0.0269	CbGeAlD
Selegiline—MAOA—decidua—uterine cancer	0.000611	0.0262	CbGeAlD
Selegiline—MAOA—renal system—uterine cancer	0.0006	0.0258	CbGeAlD
Selegiline—MAOA—endometrium—uterine cancer	0.00058	0.0249	CbGeAlD
Selegiline—MAOB—female reproductive system—uterine cancer	0.000563	0.0242	CbGeAlD
Selegiline—MAOA—mammalian vulva—uterine cancer	0.000561	0.0241	CbGeAlD
Selegiline—CYP2C8—renal system—uterine cancer	0.000535	0.023	CbGeAlD
Selegiline—MAOA—uterus—uterine cancer	0.000534	0.0229	CbGeAlD
Selegiline—CYP2C8—endometrium—uterine cancer	0.000517	0.0222	CbGeAlD
Selegiline—MAOB—female gonad—uterine cancer	0.000512	0.022	CbGeAlD
Selegiline—MAOB—vagina—uterine cancer	0.000509	0.0219	CbGeAlD
Selegiline—CYP1A2—renal system—uterine cancer	0.0005	0.0215	CbGeAlD
Selegiline—MAOA—female reproductive system—uterine cancer	0.00048	0.0206	CbGeAlD
Selegiline—CYP2B6—renal system—uterine cancer	0.00048	0.0206	CbGeAlD
Selegiline—CYP2E1—renal system—uterine cancer	0.00045	0.0193	CbGeAlD
Selegiline—CYP2C19—vagina—uterine cancer	0.000444	0.0191	CbGeAlD
Selegiline—MAOA—female gonad—uterine cancer	0.000437	0.0188	CbGeAlD
Selegiline—MAOA—vagina—uterine cancer	0.000434	0.0187	CbGeAlD
Selegiline—CYP2C8—female reproductive system—uterine cancer	0.000428	0.0184	CbGeAlD
Selegiline—CYP2C8—vagina—uterine cancer	0.000387	0.0166	CbGeAlD
Selegiline—CYP2B6—female reproductive system—uterine cancer	0.000384	0.0165	CbGeAlD
Selegiline—CYP2C9—female reproductive system—uterine cancer	0.00038	0.0163	CbGeAlD
Selegiline—CYP3A4—renal system—uterine cancer	0.000362	0.0156	CbGeAlD
Selegiline—CYP2E1—female reproductive system—uterine cancer	0.00036	0.0155	CbGeAlD
Selegiline—CYP2D6—renal system—uterine cancer	0.000356	0.0153	CbGeAlD
Selegiline—ABCB1—myometrium—uterine cancer	0.000352	0.0151	CbGeAlD
Selegiline—CYP2B6—vagina—uterine cancer	0.000347	0.0149	CbGeAlD
Selegiline—MAOB—lymph node—uterine cancer	0.000329	0.0141	CbGeAlD
Selegiline—CYP3A4—female reproductive system—uterine cancer	0.00029	0.0125	CbGeAlD
Selegiline—CYP2D6—female reproductive system—uterine cancer	0.000285	0.0123	CbGeAlD
Selegiline—MAOA—lymph node—uterine cancer	0.000281	0.0121	CbGeAlD
Selegiline—ABCB1—epithelium—uterine cancer	0.000276	0.0119	CbGeAlD
Selegiline—ABCB1—uterine cervix—uterine cancer	0.000274	0.0118	CbGeAlD
Selegiline—ABCB1—decidua—uterine cancer	0.000261	0.0112	CbGeAlD
Selegiline—CYP2D6—female gonad—uterine cancer	0.00026	0.0112	CbGeAlD
Selegiline—ABCB1—renal system—uterine cancer	0.000256	0.011	CbGeAlD
Selegiline—ABCB1—endometrium—uterine cancer	0.000248	0.0106	CbGeAlD
Selegiline—ABCB1—mammalian vulva—uterine cancer	0.00024	0.0103	CbGeAlD
Selegiline—ABCB1—uterus—uterine cancer	0.000228	0.00981	CbGeAlD
Selegiline—ABCB1—female reproductive system—uterine cancer	0.000205	0.00882	CbGeAlD
Selegiline—ABCB1—female gonad—uterine cancer	0.000187	0.00802	CbGeAlD
Selegiline—ABCB1—vagina—uterine cancer	0.000186	0.00797	CbGeAlD
Selegiline—Asthma—Epirubicin—uterine cancer	0.000125	0.000456	CcSEcCtD
Selegiline—Influenza—Epirubicin—uterine cancer	0.000125	0.000456	CcSEcCtD
Selegiline—Dysphagia—Epirubicin—uterine cancer	0.000125	0.000456	CcSEcCtD
Selegiline—Dehydration—Doxorubicin—uterine cancer	0.000124	0.000454	CcSEcCtD
Selegiline—Thrombocytopenia—Etoposide—uterine cancer	0.000124	0.000453	CcSEcCtD
Selegiline—Tachycardia—Etoposide—uterine cancer	0.000124	0.000451	CcSEcCtD
Selegiline—Eosinophilia—Epirubicin—uterine cancer	0.000124	0.000451	CcSEcCtD
Selegiline—Liver function test abnormal—Doxorubicin—uterine cancer	0.000123	0.000451	CcSEcCtD
Selegiline—Skin disorder—Etoposide—uterine cancer	0.000123	0.000449	CcSEcCtD
Selegiline—Dry skin—Doxorubicin—uterine cancer	0.000123	0.000447	CcSEcCtD
Selegiline—Hyperhidrosis—Etoposide—uterine cancer	0.000123	0.000447	CcSEcCtD
Selegiline—Orthostatic hypotension—Doxorubicin—uterine cancer	0.000122	0.000446	CcSEcCtD
Selegiline—Hypokalaemia—Doxorubicin—uterine cancer	0.000122	0.000444	CcSEcCtD
Selegiline—Angina pectoris—Epirubicin—uterine cancer	0.000122	0.000444	CcSEcCtD
Selegiline—Anorexia—Etoposide—uterine cancer	0.000121	0.000441	CcSEcCtD
Selegiline—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.00012	0.00044	CcSEcCtD
Selegiline—Bronchitis—Epirubicin—uterine cancer	0.00012	0.000439	CcSEcCtD
Selegiline—ABCB1—lymph node—uterine cancer	0.00012	0.00516	CbGeAlD
Selegiline—Diarrhoea—Dactinomycin—uterine cancer	0.00012	0.000437	CcSEcCtD
Selegiline—Hypotension—Etoposide—uterine cancer	0.000118	0.000432	CcSEcCtD
Selegiline—Gastritis—Doxorubicin—uterine cancer	0.000118	0.000432	CcSEcCtD
Selegiline—Muscular weakness—Doxorubicin—uterine cancer	0.000118	0.000431	CcSEcCtD
Selegiline—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000118	0.000431	CcSEcCtD
Selegiline—Dysuria—Epirubicin—uterine cancer	0.000117	0.000426	CcSEcCtD
Selegiline—Dysphagia—Doxorubicin—uterine cancer	0.000116	0.000422	CcSEcCtD
Selegiline—Influenza—Doxorubicin—uterine cancer	0.000116	0.000422	CcSEcCtD
Selegiline—Asthma—Doxorubicin—uterine cancer	0.000116	0.000422	CcSEcCtD
Selegiline—Pollakiuria—Epirubicin—uterine cancer	0.000115	0.000421	CcSEcCtD
Selegiline—Eosinophilia—Doxorubicin—uterine cancer	0.000114	0.000418	CcSEcCtD
Selegiline—Photosensitivity reaction—Epirubicin—uterine cancer	0.000114	0.000416	CcSEcCtD
Selegiline—Paraesthesia—Etoposide—uterine cancer	0.000114	0.000415	CcSEcCtD
Selegiline—Weight increased—Epirubicin—uterine cancer	0.000114	0.000415	CcSEcCtD
Selegiline—Weight decreased—Epirubicin—uterine cancer	0.000113	0.000413	CcSEcCtD
Selegiline—Dyspnoea—Etoposide—uterine cancer	0.000113	0.000412	CcSEcCtD
Selegiline—Hyperglycaemia—Epirubicin—uterine cancer	0.000113	0.000411	CcSEcCtD
Selegiline—Somnolence—Etoposide—uterine cancer	0.000113	0.000411	CcSEcCtD
Selegiline—Angina pectoris—Doxorubicin—uterine cancer	0.000113	0.000411	CcSEcCtD
Selegiline—Pneumonia—Epirubicin—uterine cancer	0.000112	0.000409	CcSEcCtD
Selegiline—Drowsiness—Epirubicin—uterine cancer	0.000111	0.000407	CcSEcCtD
Selegiline—Vomiting—Dactinomycin—uterine cancer	0.000111	0.000406	CcSEcCtD
Selegiline—Bronchitis—Doxorubicin—uterine cancer	0.000111	0.000406	CcSEcCtD
Selegiline—Rash—Dactinomycin—uterine cancer	0.00011	0.000403	CcSEcCtD
Selegiline—Decreased appetite—Etoposide—uterine cancer	0.00011	0.000402	CcSEcCtD
Selegiline—Gastrointestinal disorder—Etoposide—uterine cancer	0.000109	0.000399	CcSEcCtD
Selegiline—Fatigue—Etoposide—uterine cancer	0.000109	0.000399	CcSEcCtD
Selegiline—Neuropathy peripheral—Epirubicin—uterine cancer	0.000109	0.000399	CcSEcCtD
Selegiline—Stomatitis—Epirubicin—uterine cancer	0.000109	0.000396	CcSEcCtD
Selegiline—Constipation—Etoposide—uterine cancer	0.000108	0.000396	CcSEcCtD
Selegiline—Pain—Etoposide—uterine cancer	0.000108	0.000396	CcSEcCtD
Selegiline—Conjunctivitis—Epirubicin—uterine cancer	0.000108	0.000395	CcSEcCtD
Selegiline—Urinary tract infection—Epirubicin—uterine cancer	0.000108	0.000395	CcSEcCtD
Selegiline—Dysuria—Doxorubicin—uterine cancer	0.000108	0.000395	CcSEcCtD
Selegiline—Sweating—Epirubicin—uterine cancer	0.000107	0.00039	CcSEcCtD
Selegiline—Pollakiuria—Doxorubicin—uterine cancer	0.000107	0.00039	CcSEcCtD
Selegiline—Haematuria—Epirubicin—uterine cancer	0.000106	0.000388	CcSEcCtD
Selegiline—Photosensitivity reaction—Doxorubicin—uterine cancer	0.000106	0.000385	CcSEcCtD
Selegiline—Hepatobiliary disease—Epirubicin—uterine cancer	0.000105	0.000385	CcSEcCtD
Selegiline—Weight increased—Doxorubicin—uterine cancer	0.000105	0.000384	CcSEcCtD
Selegiline—Epistaxis—Epirubicin—uterine cancer	0.000105	0.000383	CcSEcCtD
Selegiline—Weight decreased—Doxorubicin—uterine cancer	0.000105	0.000382	CcSEcCtD
Selegiline—Sinusitis—Epirubicin—uterine cancer	0.000104	0.000381	CcSEcCtD
Selegiline—Feeling abnormal—Etoposide—uterine cancer	0.000104	0.000381	CcSEcCtD
Selegiline—Hyperglycaemia—Doxorubicin—uterine cancer	0.000104	0.000381	CcSEcCtD
Selegiline—Nausea—Dactinomycin—uterine cancer	0.000104	0.00038	CcSEcCtD
Selegiline—Pneumonia—Doxorubicin—uterine cancer	0.000104	0.000378	CcSEcCtD
Selegiline—Gastrointestinal pain—Etoposide—uterine cancer	0.000104	0.000378	CcSEcCtD
Selegiline—Drowsiness—Doxorubicin—uterine cancer	0.000103	0.000376	CcSEcCtD
Selegiline—Bradycardia—Epirubicin—uterine cancer	0.000102	0.000372	CcSEcCtD
Selegiline—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000101	0.000369	CcSEcCtD
Selegiline—Urticaria—Etoposide—uterine cancer	0.000101	0.000367	CcSEcCtD
Selegiline—Stomatitis—Doxorubicin—uterine cancer	0.0001	0.000367	CcSEcCtD
Selegiline—Rhinitis—Epirubicin—uterine cancer	0.0001	0.000366	CcSEcCtD
Selegiline—Abdominal pain—Etoposide—uterine cancer	0.0001	0.000366	CcSEcCtD
Selegiline—Body temperature increased—Etoposide—uterine cancer	0.0001	0.000366	CcSEcCtD
Selegiline—Urinary tract infection—Doxorubicin—uterine cancer	0.0001	0.000366	CcSEcCtD
Selegiline—Conjunctivitis—Doxorubicin—uterine cancer	0.0001	0.000366	CcSEcCtD
Selegiline—Hepatitis—Epirubicin—uterine cancer	0.0001	0.000365	CcSEcCtD
Selegiline—Hypoaesthesia—Epirubicin—uterine cancer	9.95e-05	0.000363	CcSEcCtD
Selegiline—Pharyngitis—Epirubicin—uterine cancer	9.92e-05	0.000362	CcSEcCtD
Selegiline—Sweating—Doxorubicin—uterine cancer	9.88e-05	0.000361	CcSEcCtD
Selegiline—Urinary tract disorder—Epirubicin—uterine cancer	9.87e-05	0.00036	CcSEcCtD
Selegiline—Oedema peripheral—Epirubicin—uterine cancer	9.85e-05	0.00036	CcSEcCtD
Selegiline—Haematuria—Doxorubicin—uterine cancer	9.83e-05	0.000359	CcSEcCtD
Selegiline—Urethral disorder—Epirubicin—uterine cancer	9.8e-05	0.000358	CcSEcCtD
Selegiline—Hepatobiliary disease—Doxorubicin—uterine cancer	9.75e-05	0.000356	CcSEcCtD
Selegiline—Epistaxis—Doxorubicin—uterine cancer	9.72e-05	0.000355	CcSEcCtD
Selegiline—Sinusitis—Doxorubicin—uterine cancer	9.67e-05	0.000353	CcSEcCtD
Selegiline—Visual impairment—Epirubicin—uterine cancer	9.64e-05	0.000352	CcSEcCtD
Selegiline—Bradycardia—Doxorubicin—uterine cancer	9.42e-05	0.000344	CcSEcCtD
Selegiline—Hypersensitivity—Etoposide—uterine cancer	9.34e-05	0.000341	CcSEcCtD
Selegiline—Tinnitus—Epirubicin—uterine cancer	9.32e-05	0.00034	CcSEcCtD
Selegiline—Flushing—Epirubicin—uterine cancer	9.28e-05	0.000339	CcSEcCtD
Selegiline—Rhinitis—Doxorubicin—uterine cancer	9.28e-05	0.000339	CcSEcCtD
Selegiline—Hepatitis—Doxorubicin—uterine cancer	9.25e-05	0.000338	CcSEcCtD
Selegiline—Hypoaesthesia—Doxorubicin—uterine cancer	9.21e-05	0.000336	CcSEcCtD
Selegiline—Pharyngitis—Doxorubicin—uterine cancer	9.18e-05	0.000335	CcSEcCtD
Selegiline—Urinary tract disorder—Doxorubicin—uterine cancer	9.14e-05	0.000334	CcSEcCtD
Selegiline—Oedema peripheral—Doxorubicin—uterine cancer	9.11e-05	0.000333	CcSEcCtD
Selegiline—Asthenia—Etoposide—uterine cancer	9.09e-05	0.000332	CcSEcCtD
Selegiline—Angiopathy—Epirubicin—uterine cancer	9.07e-05	0.000331	CcSEcCtD
Selegiline—Urethral disorder—Doxorubicin—uterine cancer	9.07e-05	0.000331	CcSEcCtD
Selegiline—Chills—Epirubicin—uterine cancer	8.97e-05	0.000327	CcSEcCtD
Selegiline—Pruritus—Etoposide—uterine cancer	8.97e-05	0.000327	CcSEcCtD
Selegiline—Arrhythmia—Epirubicin—uterine cancer	8.93e-05	0.000326	CcSEcCtD
Selegiline—Visual impairment—Doxorubicin—uterine cancer	8.92e-05	0.000325	CcSEcCtD
Selegiline—Alopecia—Epirubicin—uterine cancer	8.84e-05	0.000323	CcSEcCtD
Selegiline—Mental disorder—Epirubicin—uterine cancer	8.76e-05	0.00032	CcSEcCtD
Selegiline—Erythema—Epirubicin—uterine cancer	8.7e-05	0.000318	CcSEcCtD
Selegiline—Malnutrition—Epirubicin—uterine cancer	8.7e-05	0.000318	CcSEcCtD
Selegiline—Diarrhoea—Etoposide—uterine cancer	8.67e-05	0.000317	CcSEcCtD
Selegiline—Tinnitus—Doxorubicin—uterine cancer	8.63e-05	0.000315	CcSEcCtD
Selegiline—Flushing—Doxorubicin—uterine cancer	8.59e-05	0.000313	CcSEcCtD
Selegiline—Flatulence—Epirubicin—uterine cancer	8.58e-05	0.000313	CcSEcCtD
Selegiline—Tension—Epirubicin—uterine cancer	8.54e-05	0.000312	CcSEcCtD
Selegiline—Dysgeusia—Epirubicin—uterine cancer	8.52e-05	0.000311	CcSEcCtD
Selegiline—Nervousness—Epirubicin—uterine cancer	8.45e-05	0.000309	CcSEcCtD
Selegiline—Back pain—Epirubicin—uterine cancer	8.42e-05	0.000307	CcSEcCtD
Selegiline—Angiopathy—Doxorubicin—uterine cancer	8.39e-05	0.000306	CcSEcCtD
Selegiline—Dizziness—Etoposide—uterine cancer	8.38e-05	0.000306	CcSEcCtD
Selegiline—Muscle spasms—Epirubicin—uterine cancer	8.37e-05	0.000305	CcSEcCtD
Selegiline—Chills—Doxorubicin—uterine cancer	8.3e-05	0.000303	CcSEcCtD
Selegiline—Arrhythmia—Doxorubicin—uterine cancer	8.27e-05	0.000302	CcSEcCtD
Selegiline—Vision blurred—Epirubicin—uterine cancer	8.2e-05	0.000299	CcSEcCtD
Selegiline—Alopecia—Doxorubicin—uterine cancer	8.18e-05	0.000298	CcSEcCtD
Selegiline—Mental disorder—Doxorubicin—uterine cancer	8.11e-05	0.000296	CcSEcCtD
Selegiline—Ill-defined disorder—Epirubicin—uterine cancer	8.08e-05	0.000295	CcSEcCtD
Selegiline—Vomiting—Etoposide—uterine cancer	8.06e-05	0.000294	CcSEcCtD
Selegiline—Erythema—Doxorubicin—uterine cancer	8.05e-05	0.000294	CcSEcCtD
Selegiline—Malnutrition—Doxorubicin—uterine cancer	8.05e-05	0.000294	CcSEcCtD
Selegiline—Anaemia—Epirubicin—uterine cancer	8.05e-05	0.000294	CcSEcCtD
Selegiline—Agitation—Epirubicin—uterine cancer	8e-05	0.000292	CcSEcCtD
Selegiline—Rash—Etoposide—uterine cancer	7.99e-05	0.000292	CcSEcCtD
Selegiline—Dermatitis—Etoposide—uterine cancer	7.98e-05	0.000291	CcSEcCtD
Selegiline—Headache—Etoposide—uterine cancer	7.94e-05	0.00029	CcSEcCtD
Selegiline—Flatulence—Doxorubicin—uterine cancer	7.94e-05	0.00029	CcSEcCtD
Selegiline—Tension—Doxorubicin—uterine cancer	7.9e-05	0.000288	CcSEcCtD
Selegiline—Dysgeusia—Doxorubicin—uterine cancer	7.89e-05	0.000288	CcSEcCtD
Selegiline—Malaise—Epirubicin—uterine cancer	7.85e-05	0.000287	CcSEcCtD
Selegiline—Nervousness—Doxorubicin—uterine cancer	7.82e-05	0.000286	CcSEcCtD
Selegiline—Vertigo—Epirubicin—uterine cancer	7.82e-05	0.000285	CcSEcCtD
Selegiline—Syncope—Epirubicin—uterine cancer	7.81e-05	0.000285	CcSEcCtD
Selegiline—Leukopenia—Epirubicin—uterine cancer	7.79e-05	0.000284	CcSEcCtD
Selegiline—Back pain—Doxorubicin—uterine cancer	7.79e-05	0.000284	CcSEcCtD
Selegiline—Muscle spasms—Doxorubicin—uterine cancer	7.74e-05	0.000283	CcSEcCtD
Selegiline—Palpitations—Epirubicin—uterine cancer	7.69e-05	0.000281	CcSEcCtD
Selegiline—Loss of consciousness—Epirubicin—uterine cancer	7.65e-05	0.000279	CcSEcCtD
Selegiline—Cough—Epirubicin—uterine cancer	7.6e-05	0.000277	CcSEcCtD
Selegiline—Vision blurred—Doxorubicin—uterine cancer	7.59e-05	0.000277	CcSEcCtD
Selegiline—Convulsion—Epirubicin—uterine cancer	7.54e-05	0.000275	CcSEcCtD
Selegiline—Nausea—Etoposide—uterine cancer	7.53e-05	0.000275	CcSEcCtD
Selegiline—Hypertension—Epirubicin—uterine cancer	7.52e-05	0.000274	CcSEcCtD
Selegiline—Ill-defined disorder—Doxorubicin—uterine cancer	7.47e-05	0.000273	CcSEcCtD
Selegiline—Anaemia—Doxorubicin—uterine cancer	7.44e-05	0.000272	CcSEcCtD
Selegiline—Myalgia—Epirubicin—uterine cancer	7.41e-05	0.000271	CcSEcCtD
Selegiline—Chest pain—Epirubicin—uterine cancer	7.41e-05	0.000271	CcSEcCtD
Selegiline—Arthralgia—Epirubicin—uterine cancer	7.41e-05	0.000271	CcSEcCtD
Selegiline—Agitation—Doxorubicin—uterine cancer	7.4e-05	0.00027	CcSEcCtD
Selegiline—Anxiety—Epirubicin—uterine cancer	7.38e-05	0.00027	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	7.36e-05	0.000269	CcSEcCtD
Selegiline—Discomfort—Epirubicin—uterine cancer	7.32e-05	0.000267	CcSEcCtD
Selegiline—Malaise—Doxorubicin—uterine cancer	7.26e-05	0.000265	CcSEcCtD
Selegiline—Dry mouth—Epirubicin—uterine cancer	7.25e-05	0.000265	CcSEcCtD
Selegiline—Vertigo—Doxorubicin—uterine cancer	7.24e-05	0.000264	CcSEcCtD
Selegiline—Syncope—Doxorubicin—uterine cancer	7.22e-05	0.000264	CcSEcCtD
Selegiline—Leukopenia—Doxorubicin—uterine cancer	7.21e-05	0.000263	CcSEcCtD
Selegiline—Confusional state—Epirubicin—uterine cancer	7.16e-05	0.000261	CcSEcCtD
Selegiline—Palpitations—Doxorubicin—uterine cancer	7.12e-05	0.00026	CcSEcCtD
Selegiline—Oedema—Epirubicin—uterine cancer	7.1e-05	0.000259	CcSEcCtD
Selegiline—Loss of consciousness—Doxorubicin—uterine cancer	7.08e-05	0.000258	CcSEcCtD
Selegiline—Infection—Epirubicin—uterine cancer	7.06e-05	0.000258	CcSEcCtD
Selegiline—Cough—Doxorubicin—uterine cancer	7.03e-05	0.000257	CcSEcCtD
Selegiline—Shock—Epirubicin—uterine cancer	6.99e-05	0.000255	CcSEcCtD
Selegiline—Convulsion—Doxorubicin—uterine cancer	6.98e-05	0.000255	CcSEcCtD
Selegiline—Nervous system disorder—Epirubicin—uterine cancer	6.97e-05	0.000254	CcSEcCtD
Selegiline—Thrombocytopenia—Epirubicin—uterine cancer	6.96e-05	0.000254	CcSEcCtD
Selegiline—Hypertension—Doxorubicin—uterine cancer	6.95e-05	0.000254	CcSEcCtD
Selegiline—Tachycardia—Epirubicin—uterine cancer	6.93e-05	0.000253	CcSEcCtD
Selegiline—Skin disorder—Epirubicin—uterine cancer	6.9e-05	0.000252	CcSEcCtD
Selegiline—Hyperhidrosis—Epirubicin—uterine cancer	6.87e-05	0.000251	CcSEcCtD
Selegiline—Myalgia—Doxorubicin—uterine cancer	6.86e-05	0.00025	CcSEcCtD
Selegiline—Arthralgia—Doxorubicin—uterine cancer	6.86e-05	0.00025	CcSEcCtD
Selegiline—Chest pain—Doxorubicin—uterine cancer	6.86e-05	0.00025	CcSEcCtD
Selegiline—Anxiety—Doxorubicin—uterine cancer	6.83e-05	0.000249	CcSEcCtD
Selegiline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	6.81e-05	0.000249	CcSEcCtD
Selegiline—Discomfort—Doxorubicin—uterine cancer	6.77e-05	0.000247	CcSEcCtD
Selegiline—Anorexia—Epirubicin—uterine cancer	6.77e-05	0.000247	CcSEcCtD
Selegiline—Dry mouth—Doxorubicin—uterine cancer	6.71e-05	0.000245	CcSEcCtD
Selegiline—Hypotension—Epirubicin—uterine cancer	6.64e-05	0.000242	CcSEcCtD
Selegiline—Confusional state—Doxorubicin—uterine cancer	6.63e-05	0.000242	CcSEcCtD
Selegiline—Oedema—Doxorubicin—uterine cancer	6.57e-05	0.00024	CcSEcCtD
Selegiline—Infection—Doxorubicin—uterine cancer	6.53e-05	0.000238	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Epirubicin—uterine cancer	6.47e-05	0.000236	CcSEcCtD
Selegiline—Shock—Doxorubicin—uterine cancer	6.47e-05	0.000236	CcSEcCtD
Selegiline—Nervous system disorder—Doxorubicin—uterine cancer	6.45e-05	0.000235	CcSEcCtD
Selegiline—Thrombocytopenia—Doxorubicin—uterine cancer	6.44e-05	0.000235	CcSEcCtD
Selegiline—Insomnia—Epirubicin—uterine cancer	6.43e-05	0.000235	CcSEcCtD
Selegiline—Tachycardia—Doxorubicin—uterine cancer	6.42e-05	0.000234	CcSEcCtD
Selegiline—Skin disorder—Doxorubicin—uterine cancer	6.38e-05	0.000233	CcSEcCtD
Selegiline—Paraesthesia—Epirubicin—uterine cancer	6.38e-05	0.000233	CcSEcCtD
Selegiline—Hyperhidrosis—Doxorubicin—uterine cancer	6.35e-05	0.000232	CcSEcCtD
Selegiline—Dyspnoea—Epirubicin—uterine cancer	6.33e-05	0.000231	CcSEcCtD
Selegiline—Somnolence—Epirubicin—uterine cancer	6.32e-05	0.000231	CcSEcCtD
Selegiline—Anorexia—Doxorubicin—uterine cancer	6.27e-05	0.000229	CcSEcCtD
Selegiline—Dyspepsia—Epirubicin—uterine cancer	6.25e-05	0.000228	CcSEcCtD
Selegiline—Decreased appetite—Epirubicin—uterine cancer	6.18e-05	0.000225	CcSEcCtD
Selegiline—Hypotension—Doxorubicin—uterine cancer	6.14e-05	0.000224	CcSEcCtD
Selegiline—Gastrointestinal disorder—Epirubicin—uterine cancer	6.13e-05	0.000224	CcSEcCtD
Selegiline—Fatigue—Epirubicin—uterine cancer	6.12e-05	0.000224	CcSEcCtD
Selegiline—Constipation—Epirubicin—uterine cancer	6.07e-05	0.000222	CcSEcCtD
Selegiline—Pain—Epirubicin—uterine cancer	6.07e-05	0.000222	CcSEcCtD
Selegiline—Musculoskeletal discomfort—Doxorubicin—uterine cancer	5.99e-05	0.000219	CcSEcCtD
Selegiline—Insomnia—Doxorubicin—uterine cancer	5.95e-05	0.000217	CcSEcCtD
Selegiline—Paraesthesia—Doxorubicin—uterine cancer	5.9e-05	0.000215	CcSEcCtD
Selegiline—Dyspnoea—Doxorubicin—uterine cancer	5.86e-05	0.000214	CcSEcCtD
Selegiline—Feeling abnormal—Epirubicin—uterine cancer	5.85e-05	0.000214	CcSEcCtD
Selegiline—Somnolence—Doxorubicin—uterine cancer	5.84e-05	0.000213	CcSEcCtD
Selegiline—Gastrointestinal pain—Epirubicin—uterine cancer	5.81e-05	0.000212	CcSEcCtD
Selegiline—Dyspepsia—Doxorubicin—uterine cancer	5.79e-05	0.000211	CcSEcCtD
Selegiline—Decreased appetite—Doxorubicin—uterine cancer	5.71e-05	0.000209	CcSEcCtD
Selegiline—Gastrointestinal disorder—Doxorubicin—uterine cancer	5.67e-05	0.000207	CcSEcCtD
Selegiline—Fatigue—Doxorubicin—uterine cancer	5.67e-05	0.000207	CcSEcCtD
Selegiline—Urticaria—Epirubicin—uterine cancer	5.64e-05	0.000206	CcSEcCtD
Selegiline—Pain—Doxorubicin—uterine cancer	5.62e-05	0.000205	CcSEcCtD
Selegiline—Constipation—Doxorubicin—uterine cancer	5.62e-05	0.000205	CcSEcCtD
Selegiline—Body temperature increased—Epirubicin—uterine cancer	5.62e-05	0.000205	CcSEcCtD
Selegiline—Abdominal pain—Epirubicin—uterine cancer	5.62e-05	0.000205	CcSEcCtD
Selegiline—Feeling abnormal—Doxorubicin—uterine cancer	5.42e-05	0.000198	CcSEcCtD
Selegiline—Gastrointestinal pain—Doxorubicin—uterine cancer	5.38e-05	0.000196	CcSEcCtD
Selegiline—Hypersensitivity—Epirubicin—uterine cancer	5.23e-05	0.000191	CcSEcCtD
Selegiline—Urticaria—Doxorubicin—uterine cancer	5.22e-05	0.000191	CcSEcCtD
Selegiline—Abdominal pain—Doxorubicin—uterine cancer	5.2e-05	0.00019	CcSEcCtD
Selegiline—Body temperature increased—Doxorubicin—uterine cancer	5.2e-05	0.00019	CcSEcCtD
Selegiline—Asthenia—Epirubicin—uterine cancer	5.1e-05	0.000186	CcSEcCtD
Selegiline—Pruritus—Epirubicin—uterine cancer	5.03e-05	0.000183	CcSEcCtD
Selegiline—Diarrhoea—Epirubicin—uterine cancer	4.86e-05	0.000177	CcSEcCtD
Selegiline—Hypersensitivity—Doxorubicin—uterine cancer	4.84e-05	0.000177	CcSEcCtD
Selegiline—Asthenia—Doxorubicin—uterine cancer	4.72e-05	0.000172	CcSEcCtD
Selegiline—Dizziness—Epirubicin—uterine cancer	4.7e-05	0.000171	CcSEcCtD
Selegiline—Pruritus—Doxorubicin—uterine cancer	4.65e-05	0.00017	CcSEcCtD
Selegiline—Vomiting—Epirubicin—uterine cancer	4.52e-05	0.000165	CcSEcCtD
Selegiline—Diarrhoea—Doxorubicin—uterine cancer	4.5e-05	0.000164	CcSEcCtD
Selegiline—Rash—Epirubicin—uterine cancer	4.48e-05	0.000164	CcSEcCtD
Selegiline—Dermatitis—Epirubicin—uterine cancer	4.48e-05	0.000163	CcSEcCtD
Selegiline—Headache—Epirubicin—uterine cancer	4.45e-05	0.000162	CcSEcCtD
Selegiline—Dizziness—Doxorubicin—uterine cancer	4.35e-05	0.000159	CcSEcCtD
Selegiline—Nausea—Epirubicin—uterine cancer	4.22e-05	0.000154	CcSEcCtD
Selegiline—Vomiting—Doxorubicin—uterine cancer	4.18e-05	0.000153	CcSEcCtD
Selegiline—Rash—Doxorubicin—uterine cancer	4.14e-05	0.000151	CcSEcCtD
Selegiline—Dermatitis—Doxorubicin—uterine cancer	4.14e-05	0.000151	CcSEcCtD
Selegiline—Headache—Doxorubicin—uterine cancer	4.12e-05	0.00015	CcSEcCtD
Selegiline—Nausea—Doxorubicin—uterine cancer	3.9e-05	0.000143	CcSEcCtD
Selegiline—MAOA—Metabolism—STAR—uterine cancer	3e-05	0.00144	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.99e-05	0.00143	CbGpPWpGaD
Selegiline—ABCB1—Transmembrane transport of small molecules—ABCC9—uterine cancer	2.96e-05	0.00142	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.95e-05	0.00141	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	2.95e-05	0.00141	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.91e-05	0.00139	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.91e-05	0.00139	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	2.9e-05	0.00139	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP11A1—uterine cancer	2.86e-05	0.00137	CbGpPWpGaD
Selegiline—CYP1A2—Biological oxidations—CYP19A1—uterine cancer	2.85e-05	0.00137	CbGpPWpGaD
Selegiline—CYP1A2—Metapathway biotransformation—CYP19A1—uterine cancer	2.81e-05	0.00135	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.79e-05	0.00133	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKR1C3—uterine cancer	2.71e-05	0.00129	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	2.63e-05	0.00126	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.63e-05	0.00126	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.6e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.6e-05	0.00125	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—NDUFB11—uterine cancer	2.55e-05	0.00122	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—SRD5A2—uterine cancer	2.55e-05	0.00122	CbGpPWpGaD
Selegiline—ABCB1—Allograft Rejection—VEGFA—uterine cancer	2.51e-05	0.0012	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.49e-05	0.00119	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.49e-05	0.00119	CbGpPWpGaD
Selegiline—MAOA—Metabolism—POLD1—uterine cancer	2.36e-05	0.00113	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.34e-05	0.00112	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—STAR—uterine cancer	2.33e-05	0.00112	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKR1B1—uterine cancer	2.33e-05	0.00112	CbGpPWpGaD
Selegiline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	2.24e-05	0.00107	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKR1C1—uterine cancer	2.2e-05	0.00106	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—NDUFB11—uterine cancer	2.2e-05	0.00105	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—SRD5A2—uterine cancer	2.2e-05	0.00105	CbGpPWpGaD
Selegiline—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	2.2e-05	0.00105	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	2.19e-05	0.00105	CbGpPWpGaD
Selegiline—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	2.17e-05	0.00104	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	2.14e-05	0.00102	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.14e-05	0.00102	CbGpPWpGaD
Selegiline—MAOB—Metabolism—STK11—uterine cancer	2.11e-05	0.00101	CbGpPWpGaD
Selegiline—MAOB—Metabolism—CYP19A1—uterine cancer	2.11e-05	0.00101	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	2.02e-05	0.000968	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.97e-05	0.000941	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.97e-05	0.000941	CbGpPWpGaD
Selegiline—MAOA—Metabolism—RRM2—uterine cancer	1.97e-05	0.000941	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—NDUFB11—uterine cancer	1.92e-05	0.000919	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—SRD5A2—uterine cancer	1.92e-05	0.000919	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.91e-05	0.000915	CbGpPWpGaD
Selegiline—MAOA—Metabolism—DCN—uterine cancer	1.91e-05	0.000913	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.88e-05	0.000901	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—STAR—uterine cancer	1.88e-05	0.000901	CbGpPWpGaD
Selegiline—MAOA—Transmission across Chemical Synapses—HRAS—uterine cancer	1.87e-05	0.000895	CbGpPWpGaD
Selegiline—ABCB1—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.85e-05	0.000887	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—STAR—uterine cancer	1.84e-05	0.000882	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKR1B1—uterine cancer	1.84e-05	0.000882	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—POLD1—uterine cancer	1.83e-05	0.000876	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.83e-05	0.000874	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—NDUFB11—uterine cancer	1.81e-05	0.000866	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—SRD5A2—uterine cancer	1.81e-05	0.000866	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.8e-05	0.000864	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP11A1—uterine cancer	1.8e-05	0.00086	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.79e-05	0.000858	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.79e-05	0.000858	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.74e-05	0.000834	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKR1C1—uterine cancer	1.71e-05	0.000819	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKR1C3—uterine cancer	1.7e-05	0.000813	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.65e-05	0.000787	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.61e-05	0.000771	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—STAR—uterine cancer	1.59e-05	0.000763	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKR1B1—uterine cancer	1.59e-05	0.000763	CbGpPWpGaD
Selegiline—MAOB—Metabolism—MTHFR—uterine cancer	1.58e-05	0.000758	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.57e-05	0.000754	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—NDUFB11—uterine cancer	1.53e-05	0.000734	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—SRD5A2—uterine cancer	1.53e-05	0.000734	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—RRM2—uterine cancer	1.53e-05	0.00073	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.49e-05	0.000714	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.49e-05	0.000713	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—DCN—uterine cancer	1.48e-05	0.000709	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—POLD1—uterine cancer	1.48e-05	0.000707	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—POLD1—uterine cancer	1.45e-05	0.000692	CbGpPWpGaD
Selegiline—MAOA—Neuronal System—HRAS—uterine cancer	1.43e-05	0.000686	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—STAR—uterine cancer	1.42e-05	0.000681	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.42e-05	0.000681	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.41e-05	0.000675	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.41e-05	0.000673	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.41e-05	0.000673	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP11A1—uterine cancer	1.4e-05	0.000668	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—STAR—uterine cancer	1.39e-05	0.000664	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKR1B1—uterine cancer	1.39e-05	0.000664	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.38e-05	0.000661	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.37e-05	0.000657	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKR1C1—uterine cancer	1.35e-05	0.000648	CbGpPWpGaD
Selegiline—MAOA—Metabolism—STK11—uterine cancer	1.32e-05	0.000633	CbGpPWpGaD
Selegiline—MAOA—Metabolism—CYP19A1—uterine cancer	1.32e-05	0.000633	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKR1C3—uterine cancer	1.32e-05	0.000631	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.31e-05	0.000627	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—STAR—uterine cancer	1.31e-05	0.000626	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKR1B1—uterine cancer	1.31e-05	0.000626	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.3e-05	0.000621	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—STAR—uterine cancer	1.3e-05	0.000621	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.28e-05	0.000613	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—POLD1—uterine cancer	1.25e-05	0.000598	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.24e-05	0.000594	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—RRM2—uterine cancer	1.23e-05	0.000589	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—RRM2—uterine cancer	1.21e-05	0.000577	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—DCN—uterine cancer	1.2e-05	0.000572	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.18e-05	0.000566	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.18e-05	0.000566	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—DCN—uterine cancer	1.17e-05	0.00056	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKR1C1—uterine cancer	1.17e-05	0.00056	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP11A1—uterine cancer	1.13e-05	0.000539	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—POLD1—uterine cancer	1.12e-05	0.000534	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—STAR—uterine cancer	1.11e-05	0.00053	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKR1B1—uterine cancer	1.11e-05	0.00053	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP11A1—uterine cancer	1.1e-05	0.000528	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.1e-05	0.000524	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—POLD1—uterine cancer	1.09e-05	0.000521	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKR1C3—uterine cancer	1.06e-05	0.000509	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.05e-05	0.000505	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKR1C1—uterine cancer	1.04e-05	0.0005	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—RRM2—uterine cancer	1.04e-05	0.000499	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKR1C3—uterine cancer	1.04e-05	0.000499	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—CYP19A1—uterine cancer	1.03e-05	0.000491	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—STK11—uterine cancer	1.03e-05	0.000491	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—POLD1—uterine cancer	1.03e-05	0.000491	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKR1C1—uterine cancer	1.02e-05	0.000488	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—POLD1—uterine cancer	1.02e-05	0.000487	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—DCN—uterine cancer	1.01e-05	0.000484	CbGpPWpGaD
Selegiline—MAOA—Metabolism—MTHFR—uterine cancer	9.94e-06	0.000476	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	9.69e-06	0.000464	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKR1C1—uterine cancer	9.6e-06	0.00046	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP11A1—uterine cancer	9.53e-06	0.000456	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKR1C1—uterine cancer	9.52e-06	0.000456	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	9.37e-06	0.000449	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—RRM2—uterine cancer	9.3e-06	0.000445	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—RRM2—uterine cancer	9.08e-06	0.000435	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—DCN—uterine cancer	9.03e-06	0.000432	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKR1C3—uterine cancer	9e-06	0.000431	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—DCN—uterine cancer	8.81e-06	0.000422	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PTEN—uterine cancer	8.81e-06	0.000422	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—POLD1—uterine cancer	8.69e-06	0.000416	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—RRM2—uterine cancer	8.56e-06	0.00041	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—STAR—uterine cancer	8.55e-06	0.000409	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKR1B1—uterine cancer	8.55e-06	0.000409	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP11A1—uterine cancer	8.51e-06	0.000407	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—RRM2—uterine cancer	8.48e-06	0.000406	CbGpPWpGaD
Selegiline—MAOB—Metabolism—EP300—uterine cancer	8.4e-06	0.000402	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—DCN—uterine cancer	8.31e-06	0.000398	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP11A1—uterine cancer	8.3e-06	0.000398	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—STK11—uterine cancer	8.28e-06	0.000397	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—CYP19A1—uterine cancer	8.28e-06	0.000397	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—DCN—uterine cancer	8.23e-06	0.000394	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKR1C1—uterine cancer	8.13e-06	0.000389	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—CYP19A1—uterine cancer	8.11e-06	0.000388	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—STK11—uterine cancer	8.11e-06	0.000388	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKR1C3—uterine cancer	8.03e-06	0.000385	CbGpPWpGaD
Selegiline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.92e-06	0.000379	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKR1C3—uterine cancer	7.84e-06	0.000375	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP11A1—uterine cancer	7.83e-06	0.000375	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP11A1—uterine cancer	7.76e-06	0.000371	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—MTHFR—uterine cancer	7.72e-06	0.000369	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKR1C3—uterine cancer	7.39e-06	0.000354	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKR1C3—uterine cancer	7.33e-06	0.000351	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—RRM2—uterine cancer	7.25e-06	0.000347	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—DCN—uterine cancer	7.04e-06	0.000337	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—CYP19A1—uterine cancer	7.01e-06	0.000336	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—STK11—uterine cancer	7.01e-06	0.000336	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—POLD1—uterine cancer	6.71e-06	0.000321	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP11A1—uterine cancer	6.63e-06	0.000317	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	6.58e-06	0.000315	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—EP300—uterine cancer	6.28e-06	0.000301	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKR1C1—uterine cancer	6.28e-06	0.0003	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKR1C3—uterine cancer	6.26e-06	0.0003	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—STK11—uterine cancer	6.26e-06	0.0003	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—CYP19A1—uterine cancer	6.26e-06	0.0003	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—MTHFR—uterine cancer	6.22e-06	0.000298	CbGpPWpGaD
Selegiline—MAOB—Metabolism—PIK3CA—uterine cancer	6.22e-06	0.000298	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—CYP19A1—uterine cancer	6.11e-06	0.000292	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—STK11—uterine cancer	6.11e-06	0.000292	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—MTHFR—uterine cancer	6.1e-06	0.000292	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.88e-06	0.000281	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—STK11—uterine cancer	5.76e-06	0.000276	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—CYP19A1—uterine cancer	5.76e-06	0.000276	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.71e-06	0.000273	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—STK11—uterine cancer	5.71e-06	0.000273	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.6e-06	0.000268	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—RRM2—uterine cancer	5.59e-06	0.000268	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PTEN—uterine cancer	5.53e-06	0.000265	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—DCN—uterine cancer	5.43e-06	0.00026	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.36e-06	0.000256	CbGpPWpGaD
Selegiline—MAOA—Metabolism—EP300—uterine cancer	5.27e-06	0.000252	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—MTHFR—uterine cancer	5.27e-06	0.000252	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP11A1—uterine cancer	5.12e-06	0.000245	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.11e-06	0.000245	CbGpPWpGaD
Selegiline—MAOB—Metabolism—AKT1—uterine cancer	5.08e-06	0.000243	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—STK11—uterine cancer	4.88e-06	0.000233	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—CYP19A1—uterine cancer	4.88e-06	0.000233	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.83e-06	0.000231	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—MTHFR—uterine cancer	4.7e-06	0.000225	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.64e-06	0.000222	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—MTHFR—uterine cancer	4.59e-06	0.00022	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.58e-06	0.000219	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.37e-06	0.000209	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—MTHFR—uterine cancer	4.33e-06	0.000207	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PTEN—uterine cancer	4.29e-06	0.000205	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—MTHFR—uterine cancer	4.29e-06	0.000205	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.15e-06	0.000198	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—EP300—uterine cancer	4.09e-06	0.000196	CbGpPWpGaD
Selegiline—MAOA—Metabolism—PIK3CA—uterine cancer	3.9e-06	0.000187	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.78e-06	0.000181	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.76e-06	0.00018	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—STK11—uterine cancer	3.76e-06	0.00018	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—MTHFR—uterine cancer	3.67e-06	0.000175	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PTEN—uterine cancer	3.46e-06	0.000166	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PTEN—uterine cancer	3.39e-06	0.000162	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—EP300—uterine cancer	3.3e-06	0.000158	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—EP300—uterine cancer	3.23e-06	0.000155	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.23e-06	0.000155	CbGpPWpGaD
Selegiline—MAOA—Metabolism—AKT1—uterine cancer	3.19e-06	0.000153	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.03e-06	0.000145	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PTEN—uterine cancer	2.93e-06	0.00014	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—MTHFR—uterine cancer	2.83e-06	0.000135	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—EP300—uterine cancer	2.8e-06	0.000134	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PTEN—uterine cancer	2.62e-06	0.000125	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PTEN—uterine cancer	2.55e-06	0.000122	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—EP300—uterine cancer	2.5e-06	0.000119	CbGpPWpGaD
Selegiline—CYP2A6—Metabolism—AKT1—uterine cancer	2.47e-06	0.000118	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.44e-06	0.000117	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—EP300—uterine cancer	2.44e-06	0.000117	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PTEN—uterine cancer	2.41e-06	0.000115	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—PIK3CA—uterine cancer	2.39e-06	0.000115	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PTEN—uterine cancer	2.39e-06	0.000114	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—EP300—uterine cancer	2.3e-06	0.00011	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—EP300—uterine cancer	2.28e-06	0.000109	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—PIK3CA—uterine cancer	2.07e-06	9.9e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PTEN—uterine cancer	2.04e-06	9.76e-05	CbGpPWpGaD
Selegiline—CYP2B6—Metabolism—AKT1—uterine cancer	2e-06	9.55e-05	CbGpPWpGaD
Selegiline—CYP2E1—Metabolism—AKT1—uterine cancer	1.95e-06	9.36e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—EP300—uterine cancer	1.94e-06	9.31e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.85e-06	8.84e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—PIK3CA—uterine cancer	1.8e-06	8.63e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—PIK3CA—uterine cancer	1.7e-06	8.13e-05	CbGpPWpGaD
Selegiline—CYP2C8—Metabolism—AKT1—uterine cancer	1.69e-06	8.09e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.68e-06	8.06e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PTEN—uterine cancer	1.57e-06	7.53e-05	CbGpPWpGaD
Selegiline—CYP2C19—Metabolism—AKT1—uterine cancer	1.51e-06	7.22e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—EP300—uterine cancer	1.5e-06	7.18e-05	CbGpPWpGaD
Selegiline—ABCB1—Metabolism—AKT1—uterine cancer	1.47e-06	7.05e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.44e-06	6.89e-05	CbGpPWpGaD
Selegiline—CYP2D6—Metabolism—AKT1—uterine cancer	1.39e-06	6.64e-05	CbGpPWpGaD
Selegiline—CYP2C9—Metabolism—AKT1—uterine cancer	1.38e-06	6.58e-05	CbGpPWpGaD
Selegiline—CYP1A2—Metabolism—AKT1—uterine cancer	1.18e-06	5.62e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.11e-06	5.31e-05	CbGpPWpGaD
Selegiline—CYP3A4—Metabolism—AKT1—uterine cancer	9.07e-07	4.34e-05	CbGpPWpGaD
